Try our beta test site

Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) (ERLOPET)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Lung Cancer Group Cologne.
Recruitment status was:  Active, not recruiting
Information provided by:
Lung Cancer Group Cologne Identifier:
First received: December 5, 2007
Last updated: September 16, 2009
Last verified: September 2009